Polaris Venture Management Co. V, L.L.C. 13F Holdings · last filed Q3 2021
Polaris Venture Management Co. V, L.L.C. reported 6 securities worth $14.09M in its SEC 13F filing for Q3 2021 (period ended 2021-09-30). Top holdings: LYRA (71.28%), XFOR (11.70%), LIFE (8.42%). Among its top 25 positions this quarter: 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LYRA | Lyra Therapeutics, Inc. | $10.0M | 71.28% | 1.1M | Hold |
| 2 | XFOR | x4 Pharmaceuticals Inc. | $1.6M | 11.70% | 311,492 | Hold |
| 3 | LIFE | Atyr Pharma Inc. | $1.2M | 8.42% | 130,572 | Hold |
| 4 | DARE | Dare Bioscience, Inc. | $545,000 | 3.87% | 326,240 | Hold |
| 5 | GNCA | Genocea Biosciences, Inc. | $379,000 | 2.69% | 197,345 | Hold |
| 6 | PULM | Pulmatrix, Inc. | $288,000 | 2.04% | 359,441 | Hold |
| 7 | FATE | Fate Therapeutics, Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2021-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR